Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Revive Therapeutics Ltd C.RVV

Alternate Symbol(s):  RVVTF

Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It is engaged in exploring the use of Bucillamine for the potential treatment of nerve agent exposure and long COVID. The Company, through its diagnostics division, is evaluating a point-of-care in vitro diagnostic device that aids in the detection of post COVID-19 conditions or Long COVID. It also advancing the development of Psilocybin-based therapeutics through various programs. The Company's subsidiaries include Revive Therapeutics Inc. (Ontario), Revive Diagnostics Inc., and Psilocin Pharma Corp. (Ontario).


CSE:RVV - Post by User

Comment by IceColdBeeron May 03, 2021 12:57pm
79 Views
Post# 33114798

RE:RE:RE:Halt wasn't warranted.

RE:RE:RE:Halt wasn't warranted.
LMAO....  I'd love to hear you tell MF that and see how the conversations goes.  We need positive  trial results & approval to make our big move IMO.

Trippedstocks wrote:
Wow! A halt for such "big" news and just look at that impact on the stock price. Looks like it's back to halting for every little bit of news. I don't think MF understands when a halt should be requested. Next they will halt to announce they plan to engage Novatech and expand the trial in the APAC region... And plans to expand into Canada. Hahaha.


<< Previous
Bullboard Posts
Next >>